Viet Reader.

Loading...

Viet Reader.

VR.

Premier Newspaper for Vietnamese Worldwide

PR Newswire

Image: /C O R R E C T I O N -- Akeso, Inc./

/C O R R E C T I O N -- Akeso, Inc./

In the news release, Akeso's AK157D1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline, issued 21-Aug-2026 by Akeso, Inc. over PR Newswire, we are advised by the company that there are some